NMR metabolomic study in fibromyalgia
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study uses a special MRI-like test (NMR) to look at chemical changes in the body of people with fibromyalgia. It aims to better understand the condition and could help find new ways to diagnose or treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have symptoms of fibromyalgia (like widespread pain and fatigue)
- You do not have a current infection, diabetes, high blood pressure, or thyroid problems
- You are not taking antidepressants or other fibromyalgia medications
- You do not smoke or drink alcohol
- You do not have rheumatoid arthritis or lupus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non-invasive brain stimulation technique (called TMS) can help reduce pain and improve mood in women with fibromyalgia. Researchers will use MRI scans and brain stimulation to understand how pain and reward circuits in the brain work.
This trial measures two brain-related proteins (S100B and BDNF) in women with fibromyalgia compared to healthy women. It aims to find out if these proteins are linked to fibromyalgia symptoms, which could lead to better understanding or new treatments.
This study uses MRI brain scans to look for body “signals” (biomarkers) that may relate to chronic pain, including fibromyalgia. It may help researchers better understand what’s going on in the brain for people with long-term pain.
This study uses a new MRI technique to measure how metabolic fatty liver disease affects your body and to track your health over time. It aims to improve understanding of the condition and guide treatment.
This trial tests whether a nerve stimulation technique can help reduce fibromyalgia symptoms. It is open to women with a confirmed diagnosis of fibromyalgia who have had symptoms for at least three months.
This study looks at whether a specific fat-related marker (called LPC16:0) is linked to fibromyalgia. Your participation could help researchers understand what role this marker may play in the condition.
Hear when a new Fibromyalgia Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.